ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,770Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 890

$626K Total Retail Price of All Prescriptions

Rank: 184 out of 890

439 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,916 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 324 311 1 7
METFORMIN HCL 320 251 2 6
NAMENDA 311 257 3 36
LISINOPRIL 274 195 4 4
LOVASTATIN 274 192 4 46
METOPROLOL SUCCINATE 273 221 6 17
MELOXICAM 261 232 7 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 253 205 8 21
POTASSIUM CHLORIDE 250 232 9 11
CARVEDILOL 249 218 10 22
AMLODIPINE BESYLATE 243 162 11 1
CITALOPRAM HBR 233 182 12 20
SIMVASTATIN 225 167 13 5
OMEPRAZOLE 204 173 14 8
DONEPEZIL HCL 203 179 15 30
QUETIAPINE FUMARATE 189 122 16 73
ALENDRONATE SODIUM 172 136 17 38
HYDROCHLOROTHIAZIDE 171 152 18 9
ISOSORBIDE MONONITRATE ER 169 164 19 60
HYDRALAZINE HCL 168 154 20 100
METOPROLOL TARTRATE 152 127 21 15
BUSPIRONE HCL 150 104 22 133
SERTRALINE HCL 147 124 23 26
FAMOTIDINE 143 107 24 90
LEVOTHYROXINE SODIUM 139 109 25 2
TAMSULOSIN HCL 134 97 26 32
DIOVAN 134 118 26 33
CLOPIDOGREL 131 108 28 28
GABAPENTIN 121 81 29 12
ADVAIR DISKUS 116 90 30 52
FLUTICASONE PROPIONATE 116 92 30 39
CYMBALTA 115 86 32 45
HYDROCODONE-ACETAMINOPHEN 113 91 S3 33 3
ALLOPURINOL 110 107 34 31
LOSARTAN-HYDROCHLOROTHIAZIDE 108 97 35 57
NEXIUM 107 72 36 14
TRAZODONE HCL 106 81 37 40
ROPINIROLE HCL 102 76 38 93
LACTULOSE 99 82 39 112
IBUPROFEN 97 40 40 101
MEGESTROL ACETATE 95 94 R 41 92
TRAMADOL HCL 93 69 42 16
SULFAMETHOXAZOLE-TRIMETHOPRIM 92 65 43 76
LOSARTAN POTASSIUM 88 63 44 29
NOVOLIN R 87 69 45 153
DIGOXIN 87 87 45 65
SEROQUEL 82 49 47 167
RANITIDINE HCL 79 54 48 49
PLAVIX 77 59 49 42
DILTIAZEM HCL 77 66 49 235
DOXYCYCLINE HYCLATE 76 57 51 89
COMBIVENT 74 55 52 144
PHENYTOIN SODIUM EXTENDED 66 55 53 111
LYRICA 65 43 54 71
WARFARIN SODIUM 65 65 54 24
AMLODIPINE BESYLATE-BENAZEPRIL 64 45 56 41
AMITRIPTYLINE HCL 63 29 R 57 43
FLUCONAZOLE 63 38 57 155
ZOLPIDEM TARTRATE 61 54 59 19
LANTUS 57 23 60 50
PROAIR HFA 53 41 61 55
LEVOTHROID 52 52 62 306
GLYBURIDE 51 25 R 63 83
AZITHROMYCIN 51 34 63 37
LEVETIRACETAM 50 0 65 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.